April 27 (Reuters) – Chinese life sciences entrepreneur Wei
Zhou submitted a $1.5 billion bid for U.S. gene testing company
Affymetrix last month – topping a $1.3 billion agreed
acquisition by Thermo…
The post DEALTALK-U.S. companies skeptical of corporate China’s advances appeared first on NASDAQ.